acc0101 |
AKT |
phosphorylation |
Ser473 |
human |
Skin Cancer |
Colo16 |
AEE788 |
Unresolved |
4.0 |
15756022
|
acc0102 |
MAPK |
phosphorylation |
Thr202 |
human |
Skin Cancer |
Colo16 |
AEE788 |
Unresolved |
4.0 |
15756022
|
acc0103 |
MAPK |
phosphorylation |
Tyr204 |
human |
Skin Cancer |
Colo16 |
AEE788 |
Unresolved |
4.0 |
15756022
|
acc0104 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Gastric Cancer |
MGC803 |
Trametinib |
Negative |
5.0 |
33035574
|
acc0105 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 |
Unresolved |
4.0 |
16026649
|
acc0106 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + gemcitabine |
Unresolved |
4.0 |
16026649
|
acc0107 |
VEGFR |
phosphorylation |
unclear |
human |
Pancreas Cancer |
L3.6pl |
AEE788 |
Unresolved |
4.0 |
16026649
|
acc0108 |
VEGFR |
phosphorylation |
unclear |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + gemcitabine |
Unresolved |
4.0 |
16026649
|
acc0109 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 |
Unresolved |
4.0 |
16026649
|
acc0110 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + gemcitabine |
Unresolved |
4.0 |
16026649
|
acc0111 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + STI57 |
Unresolved |
4.0 |
16288027
|
acc0112 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + STI57 + gemcitabine |
Unresolved |
4.0 |
16288027
|
acc0113 |
VEGFR |
phosphorylation |
unclear |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + STI57 |
Unresolved |
4.0 |
16288027
|
acc0114 |
VEGFR |
phosphorylation |
unclear |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + STI57 + gemcitabine |
Unresolved |
4.0 |
16288027
|
acc0115 |
PDGFR |
phosphorylation |
Tyr716 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + STI57 |
Unresolved |
4.0 |
16288027
|
acc0116 |
PDGFR |
phosphorylation |
Tyr716 |
human |
Pancreas Cancer |
L3.6pl |
AEE788 + STI57 + gemcitabine |
Unresolved |
4.0 |
16288027
|
acc0117 |
PDGFR |
phosphorylation |
Tyr716 |
human |
Pancreas Cancer |
L3.6pl |
STI571 |
Unresolved |
4.0 |
16288027
|
acc0118 |
PDGFR |
phosphorylation |
Tyr716 |
human |
Pancreas Cancer |
|
GN963 |
Unresolved |
4.0 |
16773192
|
acc0119 |
beta-catenin |
phosphorylation |
Ser41 |
human |
Colorectal Cancer |
SW480 |
Aspirin |
Unresolved |
4.0 |
16878161
|
acc0120 |
beta-catenin |
phosphorylation |
Thr45 |
human |
Colorectal Cancer |
SW480 |
Aspirin |
Unresolved |
4.0 |
16878161
|
acc0121 |
PP2A |
phosphorylation |
Tyr307 |
human |
Colorectal Cancer |
SW480 |
Aspirin |
Unresolved |
4.0 |
16878161
|
acc0122 |
beta-catenin |
ubiquitination |
unclear |
human |
Colorectal Cancer |
SW480 |
Aspirin |
Unresolved |
4.0 |
16878161
|
acc0123 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
BxPC3 |
Erlotinib |
Positive |
5.0 |
16928826
|
acc0124 |
AKT |
phosphorylation |
Thr308 |
human |
Prostate Cancer |
BxPC3 |
Erlotinib |
Positive |
5.0 |
16928826
|
acc0125 |
S6 |
phosphorylation |
Ser235 |
human |
Prostate Cancer |
BxPC3 |
Erlotinib |
Positive |
5.0 |
16928826
|
acc0126 |
S6 |
phosphorylation |
Ser236 |
human |
Prostate Cancer |
BxPC3 |
Erlotinib |
Positive |
5.0 |
16928826
|
acc0127 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MCF7 |
INCB3619 |
Unresolved |
4.0 |
17363546
|
acc0128 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Breast Cancer |
MDA-MB-231 |
Gefitinib |
Negative |
5.0 |
17363546
|
acc0129 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Breast Cancer |
MDA-MB-231 |
Erlotinib |
Negative |
5.0 |
17363546
|
acc0130 |
FOXO3a |
phosphorylation |
Tyr |
human |
Breast Cancer |
BT474 |
Lapatinib |
Unresolved |
4.0 |
17513611
|
acc0131 |
FOXO3a |
phosphorylation |
Tyr |
human |
Breast Cancer |
SK-BR-3 |
Lapatinib |
Unresolved |
4.0 |
17513611
|
acc0132 |
FOXO3a |
phosphorylation |
Tyr |
human |
Breast Cancer |
MDA-MB-468 |
Lapatinib |
Unresolved |
4.0 |
17513611
|
acc0133 |
FOXO3a |
phosphorylation |
Tyr |
human |
Breast Cancer |
T47D |
Lapatinib |
Unresolved |
4.0 |
17513611
|
acc0134 |
EGFR |
phosphorylation |
Tyr |
human |
Colorectal Cancer |
HT29 |
NS-398 |
Unresolved |
4.0 |
17877615
|
acc0135 |
EGFR |
phosphorylation |
Tyr |
human |
Colorectal Cancer |
HCA7 |
NS-398 |
Unresolved |
4.0 |
17877615
|
acc0136 |
nNOS |
phosphorylation |
Ser847 |
rat |
Pituitary Tumor |
GH3 |
KN93 |
Positive |
5.0 |
18271754
|
acc0137 |
ERK1 |
phosphorylation |
Thr202 |
human |
Leukemia |
HL-60 |
Imatinib |
Positive |
5.0 |
17187856
|
acc0138 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Leukemia |
HL-60 |
Imatinib |
Positive |
5.0 |
17187856
|
acc0139 |
ERK2 |
phosphorylation |
Thr185 |
human |
Leukemia |
HL-60 |
Imatinib |
Positive |
5.0 |
17187856
|
acc0140 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Leukemia |
HL-60 |
Imatinib |
Positive |
5.0 |
17187856
|
acc0141 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Leukemia |
HL-60 |
Imatinib |
Positive |
5.0 |
17187856
|
acc0142 |
ERK1 |
phosphorylation |
Thr202 |
human |
Leukemia |
HL-60 |
AD 198 |
Unresolved |
4.0 |
17187856
|
acc0143 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Leukemia |
HL-60 |
AD 198 |
Unresolved |
4.0 |
17187856
|
acc0144 |
ERK2 |
phosphorylation |
Thr185 |
human |
Leukemia |
HL-60 |
AD 198 |
Unresolved |
4.0 |
17187856
|
acc0145 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Leukemia |
HL-60 |
AD 198 |
Unresolved |
4.0 |
17187856
|
acc0146 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Leukemia |
HL-60 |
AD 198 |
Unresolved |
4.0 |
17187856
|
acc0147 |
BCL2 |
phosphorylation |
Ser70 |
human |
Leukemia |
|
GX15-070 (Obatoclax) |
Negative |
5.0 |
18596739
|
acc0148 |
BCL2 |
phosphorylation |
Ser70 |
human |
Leukemia |
|
GX15-070 (Obatoclax) + Bortezomib |
Negative |
5.0 |
18596739
|
acc0149 |
AKT |
phosphorylation |
Ser473 |
human |
Endometrial Cancer |
Ishikawa |
Perifosine |
Unresolved |
4.0 |
18687514
|
acc0150 |
AKT |
phosphorylation |
Ser473 |
human |
Endometrial Cancer |
HEC-1A |
Perifosine |
Unresolved |
4.0 |
18687514
|